A Method to Quantify Breast MRI for Predicting Tumor Invasion in Patients with Preoperative Biopsy- Proven Ductal Carcinoma in Situ (DCIS)
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose : To determine the quantitative parameters of breast MRI that predict tumor invasion in biopsy-proven DCIS. Materials and Methods: From January 2009 to March 2010, 42 MRI examinations of 41 patients with biopsy-proven DCIS were included. The quantitative parameters, which include the initial percentage enhancement (E1), peak percentage enhancement (Epeak), time to peak enhancement (TTP), signal enhancement ratio (SER), arterial enhancement fraction (AEF), apparent diffusion coefficient (ADC) value, long diameter and the volume of the lesion, were calculated as parameters that might predict invasion. Univariate and multivariate analyses were used to identify the parameters associated with invasion. Results: Out of 42 lesions, 23 lesions were confirmed to be invasive ductal carcinoma (IDC) and 19 lesions were confirmed to be pure DCIS. Tumor size (p = 0.003; 6.5 ± 3.2 cm vs. 3.6 ± 2.6 cm, respectively) and SER (p =0.036; 1.1 ± 0.3 vs. 0.9 ± 0.3, respectively) showed statistically significant high in IDC. In contrast, E1,Epeak, TTP, ADC, AEF and volume of the lesion were not statistically significant. Tumor size and SER had statistically significant associations with invasion, with an odds ratio of 1.04 and 22.93, respectively. Conclusion: Of quantitative parameters analyzed, SER and the long diameter of the lesion could be specific parameter for predicting invasion in the biopsy-proven DCIS.
Abstract
Purpose : To determine the quantitative parameters of breast MRI that predict tumor invasion in biopsy-proven DCIS. Materials and Methods: From January 2009 to March 2010, 42 MRI examinations of 41 patients with biopsy-proven DCIS were included. The quantitative parameters, which include the initial percentage enhancement (E1), peak percentage enhancement (Epeak), time to peak enhancement (TTP), signal enhancement ratio (SER), arterial enhancement fraction (AEF), apparent diffusion coefficient (ADC) value, long diameter and the volume of the lesion, were calculated as parameters that might predict invasion. Univariate and multivariate analyses were used to identify the parameters associated with invasion. Results: Out of 42 lesions, 23 lesions were confirmed to be invasive ductal carcinoma (IDC) and 19 lesions were confirmed to be pure DCIS. Tumor size (p = 0.003; 6.5 ± 3.2 cm vs. 3.6 ± 2.6 cm, respectively) and SER (p =0.036; 1.1 ± 0.3 vs. 0.9 ± 0.3, respectively) showed statistically significant high in IDC. In contrast, E1,Epeak, TTP, ADC, AEF and volume of the lesion were not statistically significant. Tumor size and SER had statistically significant associations with invasion, with an odds ratio of 1.04 and 22.93, respectively. Conclusion: Of quantitative parameters analyzed, SER and the long diameter of the lesion could be specific parameter for predicting invasion in the biopsy-proven DCIS.
참고문헌 (34)
- Bhooshan N, "Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers", Radiology, 254, pp.680~690 (2010)
- Schnall MD, "Breast MR imaging", Radiol Clin North Am, 41, pp.43~50 (2003)
- Morris EA, "Breast cancer imaging with MRI", Radiol Clin North Am, 40, pp.443~466 (2002)
- Leonard GD, "Ductal carcinoma in situ, complexities and challenges", J Natl Cancer Inst, 96, pp.906~920 (2004)
- Ernster VL, "Detection of ductal carcinoma in situ in women undergoing screening mammography", J Natl Cancer Inst, 94, pp.1546~1554 (2002)
- "Practice guideline for the management of ductal carcinoma insitu of the breast (DCIS)", J Am Coll Surg, 205, pp.145~161 (2007)
- Hoorntje LE, "The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy", Ann Surg Oncol, 10, pp.748~753 (2003)
- Yen TW, "Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ", J Am Coll Surg, 200, pp.516~526 (2005)
- Dillon MF, "Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only", J Surg Oncol, 93, pp.559~563 (2006)
- Huang YT, "MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy", Acta Radiol, 52, pp.1064~1068 (2011)
- Lee JW, "Sonographic lesion size of ductal carcinoma in situ as a preoperative predictor for the presence of an invasive focus", J Surg Oncol, 98, pp.15~20 (2008)
- Leikola J, "Predicting invasion in patients with DCIS in the preoperative percutaneous biopsy", Acta Oncol, 46, pp.798~802 (2007)
- Wang LC, "MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation", AJR Am J Roentgenol, 193, pp.826~831 (2009)
- Chen W, "Volumetric texture analysis of breast lesions on contrast-enhanced magnetic resonance images", Magn Reson Med, 58, pp.562~571 (2007)
- Macura KJ, "Patterns of enhancement on breast MR images: interpretation and imaging pitfalls", Radiographics, 26, pp.1719~1734 (2006)
- Szabo BK, "Dynamic MR imaging of the breast. Analysis of kinetic and morphologic diagnostic criteria", Acta Radiol, 44, pp.379~386 (2003)
- Kinkel K, "Dynamic high-spatialresolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability", AJR Am J Roentgenol, 175, pp.35~43 (2000)
- Jiang Y, "Improving breast cancer diagnosis with computer-aided diagnosis", Acad Radiol, 6, pp.22~33 (1999)
- Edge S, "AJCC Cancer Staging Manual" (2010), Springer;
- Li KL, "Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging", Radiology, 248, pp.79~87 (2008)
- Esserman L, "Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma", Breast J, 5, pp.13~21 (1999)
- Grady L, "Random walks for image segmentation", T-PAMI, 6, pp.469~475 (2006)
- Baltzer PA, "Computer-aided interpretation of dynamic magnetic resonance imaging reflects histopathology of invasive breast cancer", Eur Radiol, 20, pp.1563~1571 (2010)
- Jansen SA, "Kinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrastenhanced MRI acquisition", AJR Am J Roentgenol, 193, pp.832~839 (2009)
- Santinelli A, "Microvessel quantitation in intraductal and early invasive breast carcinomas", Anal Quant Cytol Histol, 22, pp.277~284 (2000)
- Schouten van der Velden AP, "Magnetic resonance imaging of ductal carcinoma in situ: what is its clinical application? A review", Am J Surg, 198, pp.262~269 (2009)
- Kuhl CK, "Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?", Radiology, 211, pp.101~110 (1999)
- Kaiser WA, "MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations", Radiology, 170, pp.681~686 (1989)
- Kim JA, "MRI findings of pure ductal carcinoma in situ: kinetic characteristics compared according to lesion type and histopathologic factors", AJR Am J Roentgenol, 196, pp.1450~1456 (2011)
- Berg WA, "Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer", Radiology, 233, pp.830~849 (2004)
- Hylton N, "Magnetic resonance imaging of the breast : opportunities to improve breast cancer management", J Clin Oncol, 23, pp.1678~1684 (2005)
- Vieira CC, "Microinvasive ductal carcinoma in situ: clinical presentation, imaging features, pathologic findings, and outcome", Eur J Radiol, 73, pp.102~107 (2010)
- Hua X, "Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma", Diagnostic Pathology, 6, pp.111~ (2011)
- Jackman RJ, "Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates", Radiology, 218, pp.497~502 (2001)
